Employers have the right to protect their workplaces and their workers. If your brand is healthcare you have the right to protect that brand by having vaccinated employers. If your business wants to stay competitive, it can’t be shutting down every other week because of a Covid outbreak.
Likewise if my employees are continually getting breakthrough infections from unvaccinated customers then I am going to ban unvaccinated customers from my business -- like many businesses are already doing (as outlined on the Mandatory COVID Vaccine thread). A business person is not going to put up with continually being shutdown because the employees are infected.
https://theconservativetreehouse.co...yees-simultaneous-to-cdc-changing-covid-test/ The Alinsky Play is Clear – California State Joins New York City and Veterans Administration in Mandating Vaccination Shots for Employees, Simultaneous to CDC Changing COVID Test It’s all a strategic Alinsky move once you connect the dots. Earlier today New York City Mayor De Blasio announced mandated vaccinations for all 340,000 city employees. Hours later Joe Biden announced mandatory vaccinations for all 115,000 front-line employees of The Veterans Affairs department. Immediately thereafter, California Governor Gavin Newsom announced all state employees and healthcare providers will be forced to vaccinate. None of these events are disconnected. Keep in mind just a few days ago the Federal CDC announced all U.S. healthcare providers must switch to new rapid response tests for COVID-19. The reasoning? The current PCR test does not differentiate between COVID and the flu. The new tests will distinguish between the flu virus and the COVID virus. Can you see the strategic move now? The new CDC approved rapid response test will cull the flu cases from false positives; that approach will automatically drop the number of new COVID cases identified. The Biden regime will then say the drop in new COVID cases is because of the forced vaccinations in major populations (VA, NYC and CA). As a result, everyone must get vaccinated because the added vaccinations are lowering the COVID cases, and the statistics will prove it. Can you see it now? This false assertion, driven by organized manipulation of events, will then increase pressure on the remaining public to get vaccinated. The drop in COVID positive cases will create the momentum for additional COVID vaccination mandates. If we thought the pressure to vaccinate is bad now, we haven’t seen anything yet. It is going to get ugly, with threats of federal reimbursement dollars (medicare, medicaid, food and housing) withheld from states as leverage against Red State governors who do not mandate vaccinations. Vaccination passports are a guarantee in this approach; possibly even federally mandated in order to “safely vote” in the 2022 mid-term election; and the unvaccinated fear will guarantee mail-in ballots again. Services will be determined by vaccination status, and as we have seen in the election reform and voting integrity debate – corporate America will line-up to support mandatory vaccinations for retail entry or use of their products (shopping, restaurants, etc.). On a federal level – just like the VA beta-test rolled out today, a vaccination status will be weaponized by federal regulatory agencies like OSHA, Dept of Labor, USDA, HHS, HUD, Dept of Agriculture, Dept of Education, etc. All of this will be politically pressurized for a Vaxxed -vs- Non Vaxxed mid term election in 2022. That’s the Alinsky play… Right now they are probing for reaction… That’s exactly what this looks like.
You are pushing nonsense again... your claim is that the CDC is stating that U.S. test providers must switch to Rapid tests -- in fact most will switch to PCR tests based on a different genome assay. All the CDC is requiring is that U.S. providers switch away from using the original genome provided early in February 2020 as a basis of testing. Using later assay capabilities will allow the tests to be more accurate for COVID including variants and allow the tests to also test for Flu variants. The intent is to prevent false negatives, NOT false positives. And to allow a single test to be used for both COVID and the Flu rather than two different tests. I should note that most testing organizations have moved on from using the original February 2020 assay many months ago -- so few will need to make any changes. Let's read the CDC announcement from their website... 07/21/2021: Lab Alert: Changes to CDC RT-PCR for SARS-CoV-2 Testing https://www.cdc.gov/csels/dls/locs/...-Changes_CDC_RT-PCR_SARS-CoV-2_Testing_1.html Audience: Individuals Performing COVID-19 Testing Level: Laboratory Alert After December 31, 2021, CDC will withdraw the request to the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) of the CDC 2019-Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel, the assay first introduced in February 2020 for detection of SARS-CoV-2 only. CDC is providing this advance notice for clinical laboratories to have adequate time to select and implement one of the many FDA-authorized alternatives. Visit the FDA website for a list of authorized COVID-19 diagnostic methods. For a summary of the performance of FDA-authorized molecular methods with an FDA reference panel, visit this page. In preparation for this change, CDC recommends clinical laboratories and testing sites that have been using the CDC 2019-nCoV RT-PCR assay select and begin their transition to another FDA-authorized COVID-19 test. CDC encourages laboratories to consider adoption of a multiplexed method that can facilitate detection and differentiation of SARS-CoV-2 and influenza viruses. Such assays can facilitate continued testing for both influenza and SARS-CoV-2 and can save both time and resources as we head into influenza season. Laboratories and testing sites should validate and verify their selected assay within their facility before beginning clinical testing. Opt in to receive updates from the CDC Laboratory Outreach Communication System (LOCS). Online resources: FAQ: CDC Distribution of COVID-19 Assays Guidance for SARS-CoV-2 Point-of-Care Testing Interim Guidance for SARS-CoV-2 Antigen Testing Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens for COVID-19 Frequently Asked Questions about COVID-19 for Laboratories Information for Laboratories about COVID-19 CDC COVID-19 Website Clinical Laboratory COVID-19 Response Weekly Calls CDC Laboratory Outreach Communication System (LOCS) If you have any questions, please contact us at LOCS@cdc.gov. Thank you, The Laboratory Outreach Communication System Laboratory Outreach Communication System (LOCS) | Division of Laboratory Systems (DLS) Center for Surveillance, Epidemiology, and Laboratory Services (CSELS) Centers for Disease Control and Prevention (CDC) LOCS@cdc.gov www.cdc.gov/csels/dls/locs
Pfizer data suggest third dose of Covid-19 vaccine 'strongly' boosts protection against Delta variant https://www.wral.com/pfizer-data-su...ts-protection-against-delta-variant/19795498/ A third dose of the Pfizer/BioNTech Covid-19 vaccine can "strongly" boost protection against the Delta variant -- beyond the protection afforded by the standard two doses, suggests new data released by Pfizer on Wednesday. The data posted online, which are expected to be discussed in a company earnings call on Wednesday morning, suggest that antibody levels against the Delta variant in people ages 18 to 55 who receive a third dose of vaccine are greater than five-fold than following a second dose. Among people ages 65 to 85, the Pfizer data suggest that antibody levels against the Delta variant after receiving a third dose of vaccine are greater than 11-fold than following a second dose. There's "estimated potential for up to 100-fold increase in Delta neutralization post-dose three compared to pre-dose three," researchers wrote in the Pfizer data slides. The data have not yet been peer-reviewed or published. The data also show that antibody levels are much higher after a third dose than a second dose against the original coronavirus variant and the Beta variant, first identified in South Africa.
https://en.wikipedia.org/wiki/Antibody-dependent_enhancement Antibody-dependent enhancement (ADE), sometimes less precisely called immune enhancement or disease enhancement, is a phenomenon in which binding of a virus to suboptimal antibodies enhances its entry into hostcells, followed by its replication.[1][2] ADE may cause enhanced respiratory disease and acute lung injury after respiratory virus infection (ERD) with symptoms of monocytic infiltration and an excess of eosinophils in respiratory tract.[3] ADE along with type 2 T helper cell-dependent mechanisms may contribute to a development of the vaccine associated disease enhancement (VADE), which is not limited to respiratory disease.[3] Some vaccine candidates that targeted coronaviruses, RSV virus and Dengue virus elicited VADE, and were terminated from further development or became approved for use only for patients who have had those viruses before. Coronavirus Further information: Misinformation related to the COVID-19 pandemic ADE was a concern during late clinical stages of vaccine development against COVID-19.[25][26] ADE was observed in animal studies during the development of coronavirus vaccines, but as of 14 December 2020 no incidents had been observed in human trials. "Overall, while ADE is a theoretical possibility with a COVID-19 vaccine, clinical trials in people so far have not shown that participants who received the vaccine have a higher rate of severe illness compared to participants who did not receive the vaccine."[27][28]
Yep… this idiot Malone pushing nonsense that has already been debunked as not being an issue for Covid vaccines. Why don’t you go read some of the easily available fact checks regarding ADE.